[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345020-105":59,"doc-detail-345020-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cell-mediated-immunity-against-human-papillomavirus-infection-review-from-viral-clearance-to-oncogenesis","Cell-Mediated Immunity Against Human Papillomavirus Infection - Review - From Viral Clearance to Oncogenesis","","Human papillomavirus (HPV), especially high-risk types, remains a major public health threat because it is linked to multiple cancers and heightened susceptibility to other sexually transmitted infections. In most cases, host immunity clears HPV rapidly, yet persistence or latency enables progression toward malignancy. This review synthesizes immune mechanisms driving control and failure, emphasizing T cells and other immune subsets, describing HPV immune evasion and immune microenvironment remodeling, and outlining current and emerging immunotherapeutic directions.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cell-mediated-immunity-against-human-papillomavirus-infection-review-from-viral-clearance-to-oncogenesis/345020/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cell-mediated-immunity-against-human-papillomavirus-infection-review-from-viral-clearance-to-oncogenesis/345020.png","ImageObject",300,407,{"name":92,"@type":93},"Ivy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is high-risk HPV considered a significant public health concern?","Question",{"text":112,"@type":113},"High-risk HPV types are associated with various cancers and can increase the likelihood of acquiring other sexually transmitted infections.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What determines whether an HPV infection is cleared or becomes persistent?",{"text":117,"@type":113},"In most people, infections are resolved spontaneously, but persistence can occur and risk rises based on factors such as viral type and viral load, along with other host and exposure variables discussed in the review.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the review connect immune evasion with cancer progression and therapy development?",{"text":121,"@type":113},"It explains that understanding how HPV interacts with and evades immune responses—especially T cell-mediated mechanisms—and how it modulates the immune microenvironment can inform improved strategies for treating HPV-related diseases, including vaccine-based and immunotherapeutic approaches.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345020,1790493901,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Review  \nCell-Mediated Immunity Against Human Papillomavirus Infection: From Viral Clearance to Oncogenesis  \nDiana Savage 1,2, Jiafen Hu 3, Adam D. Burgener 4, Afshin Raouf 1,2 and Thomas T. Murooka 1, *  \nAcademic Editor: Joe S. Mymryk  \nReceived: 4 January 2026  \nRevised: 18 February 2026  \nAccepted: 7 March 2026  \nPublished: 16 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Immunology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0T5, Canada; [topolni3@myumanitoba.ca](topolni3@myumanitoba.ca) (D.S.); [afshin.raouf@umanitoba.ca](afshin.raouf@umanitoba.ca) (A.R.)  \n2 Paul Albrechtsen Research Institute, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada  \n3 Department of Pathology and Laboratory Medicine, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA; [fjh4@psu.edu](fjh4@psu.edu)  \n4 Center for Global Health and Diseases, Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA; [adam.burgener@case.edu](adam.burgener@case.edu)  \n* Correspondence: [thomas.murooka@umanitoba.ca](thomas.murooka@umanitoba.ca)  \nAbstract  \nHuman papillomavirus (HPV), especially high-risk HPV types, is a significant public health concern due to its association with various cancers and increased risk of acquiring other sexually transmitted infections (STIs) . In most cases, host immunity rapidly responds to and clears HPV infections, but persistent or latent infections can increase susceptibility to cancer. A better understanding of how HPV interacts with and evades the immune response is vital to understanding disease progression and guiding the next generation of vaccines and immunotherapies. This review article provides a comprehensive overview of the immune mechanisms involved in HPV infection, highlighting the roles of T cells and other immune subsets. We discuss the immune evasion strategies employed by HPV and subsequent modulation of the immune microenvironment. Additionally, we explore the current therapeutic landscape and emerging immunotherapeutic approaches under investigation. By unveiling the intricacies of the immune response to HPV, we may inform improved strategies for the treatment of HPV-related diseases.  \nKeywords: human papillomavirus; mucosal infection; cutaneous infection; cell-mediated immunity; T cell response; immunotherapy  \n1. Introduction  \nHuman papillomaviruses (HPVs) are a large and diverse family of small doublestranded DNA viruses that are divided into five genera: alpha (α), beta (β), gamma (γ), mu (µ), and nu (ν) . Of these, the α-and β-HPVs have garnered the most attention due to their associations with human health [1–6] . Currently, more than 400 HPV types have been identified [7] . α-HPVs primarily infect the mucosal epithelium and are comprised of both low-and high-risk types based on their ability to cause malignant transformation of infected tissue. Broadly, high-risk HPV16 and HPV18 are the predominant drivers of virus-induced pathogenicity, linked to the development of oropharyngeal, anal, penile, cervical, vaginal, and/or vulvar cancers, whereas low-risk HPV6 and HPV11 are typically associated with benign genital warts [8] . β-HPVs primarily cause transient infections of the skin but are a frequent cause of skin cancers such as cutaneous squamous cell carcinoma (cSCC) in immunocompromised individuals [2–4] . The ability of HPV to establish chronic infection at these tissue sites has important implications for tissue pathology and cancer  \ndevelopment and remains a key research area in the absence of an approved therapeutic vaccine. In this review, we provide an overview of how the cutaneous and mucosal tissues generate critical cell-mediated immune responses against HPV infection, with a focus on CD8+ and CD4+ T cell re","cbCaik1DgHvn6OaG","https://ap.wps.com/l/cbCaik1DgHvn6OaG","pdf",1095239,22,"English","# Abstract\n# Introduction\n## Etiology and Epidemiology of HPV Infection\n## Pattern and Prevalence of HPV Infection and HPV-Induced Cancers","[{\"question\":\"Why is high-risk HPV considered a significant public health concern?\",\"answer\":\"High-risk HPV types are associated with various cancers and can increase the likelihood of acquiring other sexually transmitted infections.\"},{\"question\":\"What determines whether an HPV infection is cleared or becomes persistent?\",\"answer\":\"In most people, infections are resolved spontaneously, but persistence can occur and risk rises based on factors such as viral type and viral load, along with other host and exposure variables discussed in the review.\"},{\"question\":\"How does the review connect immune evasion with cancer progression and therapy development?\",\"answer\":\"It explains that understanding how HPV interacts with and evades immune responses—especially T cell-mediated mechanisms—and how it modulates the immune microenvironment can inform improved strategies for treating HPV-related diseases, including vaccine-based and immunotherapeutic approaches.\"}]","Cell-Mediated Immunity Against Human Papillomavirus Infection - Review - From Viral Clearance to Oncogenesis | PDF",1790056240,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/968cf52c3075414f6699e3352f584324.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/25e3350c6b0f1d176bb4adc6713efd16.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8cbdcf123310a0d24812285e4542a6b2.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65c7ba54d3f9cf1144b289bff649b4e8.webp",980,1385]